L. Hansen Carl - Dec 31, 2021 Form 5 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/3/2022, 05:56 PM
Previous filing
Dec 9, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Gift $0 -224K -100% $0.00* 0 May 24, 2021 See Footnote F1, F2, F3
transaction ABCL Common Shares Gift $0 -1.25M -2.24% $0.00 54.6M May 24, 2021 See Footnote F4, F5
transaction ABCL Common Shares Gift $0 -750K -1.37% $0.00 53.8M Dec 7, 2021 See Footnote F5, F6
holding ABCL Common Shares 225K Dec 31, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a charitable donation of 223,500 common shares donated by Hankla Family Trust (2019) on May 24, 2021.
F2 Due to clerical error, the number of shares held by Hankla Family Trust (2019) was overstated by 10,000 shares on the reporting person's prior Form 4 filings.
F3 These shares are held by Hankla Family Trust (2019), of which the reporting person and his spouse are joint trustees. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
F4 This transaction represents a charitable donation of 1,250,000 common shares donated by Thermopylae Holdings Ltd. on May 24, 2021.
F5 These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
F6 This transaction represents a charitable donation of 750,000 common shares donated by Thermopylae Holdings Ltd. on December 7, 2021.